Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating inflammatory disorder with antibodies directed against interleukin-33 (IL-33)

Method of treating inflammatory disorder with antibodies directed against interleukin-33 (IL-33)

US Patent 10836820 · Granted Nov 17, 2020

Estimated economic value: $5,237,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions comprising anti-NRP2 antibodies2025
Antibodies directed against interleukin 36 receptor (IL-36R)2025
Antibodies directed against interleukin 36 receptor (IL-36R)2025
Anti-IL-18BP antibodies2025
Anti-IL-18BP antibodies2025
Method of treating an interleukin-11-associated or -mediated fibrotic disease or2025
Method of treating an interleukin-11-associated or -mediated fibrotic disease or2025
FN14 antibodies and uses thereof2025
Anti-interleukin-11 receptor subunit α (IL-11Rα) antibodies2024
Anti-interleukin-11 receptor subunit α (IL-11Rα) antibodies2024
Compositions and methods comprising anti-NRP2 antibodies2024
Method of treating autoimmune disease with antibodies against IL-332024